Characterization of novel MPS1 inhibitors with preclinical anticancer activity.

Cell Death & Differentiation

20 novembre 2013
Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.

Jemaà M, Galluzzi L, Kepp O, Senovilla L, Brands M, Boemer U, Koppitz M, Lienau P, Prechtl S, Schulze V, Siemeister G, Wengner AM, Mumberg D, Ziegelbauer K, Abrieu A, Castedo M, Vitale I,Kroemer